Title : The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.

Pub. Date : 2013 Nov 28

PMID : 23933235






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Despite the clinical introduction of an increasing number of polyethylene glycol (PEG)-conjugated substances, PEG has been named as the cause of an unexpected immunogenic response known as the "accelerated blood clearance (ABC) phenomenon." Polyethylene Glycols ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens
2 Despite the clinical introduction of an increasing number of polyethylene glycol (PEG)-conjugated substances, PEG has been named as the cause of an unexpected immunogenic response known as the "accelerated blood clearance (ABC) phenomenon." Polyethylene Glycols ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens
3 In addition, the clinical implications of the ABC phenomenon on the therapeutic efficacy of PEG-conjugated substances/PEGylated nanocarriers, along with the new approaches that can be applied to manage and/or abrogate the induction of the ABC phenomenon, are also discussed. Polyethylene Glycols ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens
4 In addition, the clinical implications of the ABC phenomenon on the therapeutic efficacy of PEG-conjugated substances/PEGylated nanocarriers, along with the new approaches that can be applied to manage and/or abrogate the induction of the ABC phenomenon, are also discussed. Polyethylene Glycols ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens